Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Is Inclusive Occupational Therapy for People Living With Dementia? Lessons From Collaborative Workshops With Diverse Communities.

Australasian journal on ageing·2026
Same author

Facing Dementia in Primary Care: Applying the COM-B Model to Develop a Complex Intervention to Improve Dementia Diagnosis Rates in General Practice.

International journal of environmental research and public health·2026
Same author

Equitable Digital Frailty Screening for Marginalized Older Adults Using Audio Computer-Assisted Self-Interview: Collaborative Development Guide and User Testing Study.

JMIR formative research·2026
Same author

The characteristics and performance of health data domains in supporting dementia identification: A systematic review.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

A culturally tailored iSupport model for dementia carers: Study protocol for a hybrid type I randomised controlled trial.

International journal of nursing studies advances·2026
Same author

Cognition and other determinants of wellbeing in old age: a 12 year longitudinal study.

Aging & mental health·2026

Related Experiment Video

Updated: Jun 24, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

Translating dementia research into practice.

Brian Draper1, Lee-Fay Low, Adrienne Withall

  • 1School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia. b.draper@unsw.edu.au

International Psychogeriatrics
|March 18, 2009
PubMed
Summary

Bridging the dementia knowledge gap requires effective knowledge translation (KT). This involves researchers, clinicians, and policymakers working together to implement research findings into dementia care and policy.

Related Experiment Videos

Last Updated: Jun 24, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

Area of Science:

  • Gerontology
  • Health Services Research
  • Knowledge Translation

Background:

  • A significant gap exists between dementia research findings and their practical application in clinical settings.
  • Knowledge translation (KT) is crucial for bridging this gap, facilitating the use of research in dementia care.

Purpose of the Study:

  • To examine the concept and process of knowledge translation (KT) in the field of dementia.
  • To identify challenges and key features of effective KT strategies for dementia research.

Main Methods:

  • This review synthesizes existing literature on knowledge translation within the dementia research domain.
  • It analyzes the roles of various stakeholders and identifies common barriers and facilitators.

Main Results:

  • Effective KT involves a network of researchers, educators, clinicians, policymakers, and the public.
  • Challenges include research volume, unclear responsibilities, premature translation, resource limitations, and workforce characteristics.
  • Key features of effective KT include clear messaging, interpersonal contact, practical frameworks, and resource support.

Conclusions:

  • Enhancing dementia care necessitates a collaborative commitment from stakeholders to improve KT strategies.
  • Adequate resources and a focus on evidence-based information are vital for successful knowledge translation in dementia.